The increased risk of angioedema was attributed to elevated levels of bradykinin, a result of the simultaneous inhibition of three bradykinin-degrading proteases: ACE, NEP, and aminopeptidase (Sulpizio et al., 2005), resulting in excessive vasodilation and vascular permeability. Here, MME is linked to angioedema.